These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6802553)

  • 1. The identification of high risk knee bleeds in adolescents with severe haemophilia A.
    Aronstam A; Wassef M; Hamad Z; Aston DL
    Clin Lab Haematol; 1982; 4(1):17-21. PubMed ID: 6802553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind controlled trial of two dose levels of factor VIII in the treatment of high risk haemarthroses in haemophilia A.
    Aronstam A; Wassef M; Hamad Z; Cartlidge J; McLellan D
    Clin Lab Haematol; 1983; 5(2):157-63. PubMed ID: 6411418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A.
    Aronstam A; Wasssef M; Choudhury DP; Turk PM; McLellan DS
    Lancet; 1980 Jan; 1(8161):169-71. PubMed ID: 6101631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bleeding patterns on the response of haemophilic haemarthroses to different doses of factor VIII.
    Aronstam A; Wassef M; Hamad Z; McLellan DS
    Clin Lab Haematol; 1981; 3(2):107-12. PubMed ID: 6788433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful angiographic embolization of recurrent elbow and knee joint bleeds in seven patients with severe haemophilia.
    Klamroth R; Gottstein S; Essers E; Landgraf H; Wilaschek M; Oldenburg J
    Haemophilia; 2009 Jan; 15(1):247-52. PubMed ID: 18691374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion requirements of adolescents with severe haemophilia A.
    Aronstam A; McLellan DS; Turk P
    J Clin Pathol; 1979 Sep; 32(9):927-30. PubMed ID: 512053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of an activated factor IX complex (Autoplex) in the management of haemarthroses in haemophiliacs with antibodies to factor VIII.
    Aronstam A; McLellan DS; Mbatha PS; Wassef M
    Clin Lab Haematol; 1982; 4(3):231-8. PubMed ID: 6816500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of early haemarthroses in severely affected adolescent haemophiliacs.
    Aronstam A; Browne RS; Wassef M; Hamad Z
    Clin Lab Haematol; 1984; 6(1):9-15. PubMed ID: 6734103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of factor VIII for selected ankle bleeds in severe haemophilia A.
    Aronstam A; Wassef M; Hamad Z
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):790. PubMed ID: 6802229
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose factor VIII in adults with haemophilic arthropathy.
    Harris RI; Stuart J
    Lancet; 1979 Jan; 1(8107):93-4. PubMed ID: 84140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint bleeds increase the inhibitor response to human factor VIII in a rat model of severe haemophilia A.
    Lövgren KM; Søndergaard H; Skov S; Wiinberg B
    Haemophilia; 2016 Sep; 22(5):772-9. PubMed ID: 27439658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical features of early bleeding into the muscles of the lower limb in severe haemophiliacs.
    Aronstam A; Browne RS; Wassef M; Hamad Z
    J Bone Joint Surg Br; 1983 Jan; 65(1):19-23. PubMed ID: 6401743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).
    Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B;
    Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative Approach in Haemophillic Arthropathy of The Knee: a Case Report.
    Lubis AM; Husodo K; Sukrisman L; Gatot D
    Acta Med Indones; 2015 Oct; 47(4):326-32. PubMed ID: 26932702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemophilic arthropathy of the knee joint. Treatment of hemorrhages of the knee-joint and their consequences].
    Landbeck G; Kurme A
    Monatsschr Kinderheilkd (1902); 1970 Feb; 118(2):29-41. PubMed ID: 5522402
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
    Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.
    Fischer K; Collins P; Björkman S; Blanchette V; Oh M; Fritsch S; Schroth P; Spotts G; Ewenstein B
    Haemophilia; 2011 May; 17(3):433-8. PubMed ID: 21299740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.